Subunit Vaccine Approaches for African Swine Fever Virus.
ASFV
African swine fever virus
antibody dependent enhancement
antigens
disease enhancement
immunogens
protective immunity
subunit vaccines
vaccines
Journal
Vaccines
ISSN: 2076-393X
Titre abrégé: Vaccines (Basel)
Pays: Switzerland
ID NLM: 101629355
Informations de publication
Date de publication:
25 Jun 2019
25 Jun 2019
Historique:
received:
19
05
2019
revised:
21
06
2019
accepted:
21
06
2019
entrez:
28
6
2019
pubmed:
28
6
2019
medline:
28
6
2019
Statut:
epublish
Résumé
African swine fever virus (ASFV) is the cause of a highly fatal disease in swine, for which there is no available vaccine. The disease is highly contagious and poses a serious threat to the swine industry worldwide. Since its introduction to the Caucasus region in 2007, a highly virulent, genotype II strain of ASFV has continued to circulate and spread into Eastern Europe and Russia, and most recently into Western Europe, China, and various countries of Southeast Asia. This review summarizes various ASFV vaccine strategies that have been investigated, with focus on antigen-, DNA-, and virus vector-based vaccines. Known ASFV antigens and the determinants of protection against ASFV versus immunopathological enhancement of infection and disease are also discussed.
Identifiants
pubmed: 31242632
pii: vaccines7020056
doi: 10.3390/vaccines7020056
pmc: PMC6631172
pii:
doi:
Types de publication
Journal Article
Review
Langues
eng
Subventions
Organisme : U.S. Department of Homeland Security
ID : DHS-2010-ST-061-AG0001
Organisme : State of Kansas National Bio and Agro-Defense Facility transition funds
ID : NA
Références
J Gen Virol. 2001 Mar;82(Pt 3):513-23
pubmed: 11172092
Arch Virol. 2001;146(9):1681-91
pubmed: 11699955
J Gen Virol. 2002 Jun;83(Pt 6):1331-42
pubmed: 12029148
Virology. 2004 Feb 20;319(2):337-42
pubmed: 14980493
J Gen Virol. 2005 Sep;86(Pt 9):2445-50
pubmed: 16099902
Nat New Biol. 1973 May 2;243(122):24-6
pubmed: 17319077
J Gen Virol. 2007 Sep;88(Pt 9):2426-34
pubmed: 17698651
J Gen Virol. 2008 Feb;89(Pt 2):397-408
pubmed: 18198370
Emerg Infect Dis. 2008 Dec;14(12):1870-4
pubmed: 19046509
Clin Vaccine Immunol. 2009 Jul;16(7):1012-20
pubmed: 19420186
Philos Trans R Soc Lond B Biol Sci. 2009 Sep 27;364(1530):2683-96
pubmed: 19687038
Virology. 2010 Apr 25;400(1):128-36
pubmed: 20171711
Lancet Infect Dis. 2010 Oct;10(10):712-22
pubmed: 20883967
Emerg Infect Dis. 2011 Apr;17(4):599-605
pubmed: 21470447
Vaccine. 2011 Jun 20;29(28):4593-600
pubmed: 21549789
Vaccine. 2011 Jul 26;29(33):5379-85
pubmed: 21679736
PLoS One. 2012;7(9):e40942
pubmed: 23049728
Virus Res. 2013 Apr;173(1):191-7
pubmed: 23123296
Virus Res. 2013 Apr;173(1):122-30
pubmed: 23137735
Virus Res. 2013 Apr;173(1):3-14
pubmed: 23142553
Virus Res. 2013 Apr;173(1):101-9
pubmed: 23159730
Virus Res. 2013 Apr;173(1):198-203
pubmed: 23266725
Antiviral Res. 2013 Apr;98(1):61-5
pubmed: 23428670
Virology. 2013 Aug 15;443(1):99-105
pubmed: 23725691
Vaccine. 2014 Jun 30;32(31):3879-82
pubmed: 24877766
Emerg Infect Dis. 2014 Sep;20(9):1544-7
pubmed: 25148518
J Virol. 2014 Nov;88(22):13322-32
pubmed: 25210179
J Gen Virol. 2015 Apr;96(Pt 4):866-73
pubmed: 25524164
Emerg Infect Dis. 2015 Feb;21(2):312-5
pubmed: 25625574
Transbound Emerg Dis. 2016 Oct;63(5):e323-7
pubmed: 25691347
J Virol. 2015 Jun;89(11):6048-56
pubmed: 25810553
Epidemiol Infect. 2016 Jan;144(1):25-34
pubmed: 25989921
J Virol. 2015 Aug;89(16):8556-66
pubmed: 26063424
Transbound Emerg Dis. 2017 Apr;64(2):425-431
pubmed: 26104842
Immunol Rev. 2015 Nov;268(1):340-64
pubmed: 26497532
Vet Rec. 2016 Mar 12;178(11):262-7
pubmed: 26966305
Virol Sin. 2016 Apr;31(2):150-9
pubmed: 26980334
Transbound Emerg Dis. 2017 Oct;64(5):1393-1404
pubmed: 27211823
Vaccine. 2016 Sep 7;34(39):4698-4705
pubmed: 27521231
Clin Vaccine Immunol. 2016 Nov 4;23(11):888-900
pubmed: 27628166
J Virol. 2016 Dec 16;91(1):
pubmed: 27795430
Vet Immunol Immunopathol. 2017 Mar;185:20-33
pubmed: 28241999
PLoS One. 2017 May 8;12(5):e0177007
pubmed: 28481911
J Virol. 2017 Oct 13;91(21):
pubmed: 28814514
Transbound Emerg Dis. 2018 Apr;65(2):420-431
pubmed: 28921895
J Virol. 2017 Nov 30;91(24):
pubmed: 28978700
J Virol. 2018 Mar 28;92(8):
pubmed: 29386289
J Gen Virol. 2018 May;99(5):613-614
pubmed: 29565243
Vaccine. 2018 May 3;36(19):2694-2704
pubmed: 29609966
Transbound Emerg Dis. 2018 Dec;65(6):1482-1484
pubmed: 30102848
Emerg Infect Dis. 2018 Nov;24(11):2131-2133
pubmed: 30141772
J Virol. 2018 Nov 12;92(23):
pubmed: 30185597
Arch Virol. 2019 Feb;164(2):359-370
pubmed: 30367292
Transbound Emerg Dis. 2019 Jan;66(1):54-55
pubmed: 30383329
Emerg Infect Dis. 2019 Jan;25(1):184-186
pubmed: 30387416
Transbound Emerg Dis. 2019 Mar;66(2):672-686
pubmed: 30633851
Porcine Health Manag. 2019 Jan 9;5:6
pubmed: 30637117
Vaccines (Basel). 2019 Jan 28;7(1):null
pubmed: 30696015
Vet Immunol Immunopathol. 2019 Feb;208:34-43
pubmed: 30712790
Emerg Infect Dis. 2019 May;25(5):891-897
pubmed: 30761988
Viruses. 2019 Mar 30;11(4):null
pubmed: 30935026
Virus Res. 2019 Apr 3;271:197614
pubmed: 30953662
Proc Soc Exp Biol Med. 1970 Jun;134(2):367-71
pubmed: 4192541
Am J Vet Res. 1967 Mar;28(123):475-81
pubmed: 4291851
Virology. 1994 Jun;201(2):413-8
pubmed: 7514322
Virology. 1993 Oct;196(2):596-602
pubmed: 7690502
Virology. 1993 Oct;196(2):769-77
pubmed: 8372447
Virology. 1996 Apr 1;218(1):285-9
pubmed: 8615037
Viral Immunol. 1996;9(1):51-63
pubmed: 8733920
J Virol. 1996 Aug;70(8):5689-94
pubmed: 8764090
Virus Res. 1997 Jan;47(1):31-40
pubmed: 9037734
Virology. 1998 Apr 10;243(2):461-71
pubmed: 9568043